Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.52M P/E - EPS this Y - Ern Qtrly Grth -
Income -8.21M Forward P/E - EPS next Y - 50D Avg Chg -8.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -28.00%
Dividend N/A Price/Book 0.87 EPS next 5Y - 52W High Chg -60.00%
Recommedations 2.00 Quick Ratio 0.58 Shares Outstanding 34.29M 52W Low Chg 15.00%
Insider Own 4.66% ROA -52.02% Shares Float 27.26M Beta 1.22
Inst Own 6.70% ROE -103.21% Shares Shorted/Prior 300.41K/131.89K Price 0.82
Gross Margin - Profit Margin - Avg. Volume 977,687 Target Price -
Oper. Margin - Earnings Date - Volume 29,182 Change -0.39%
About Sharps Technology Inc.

Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

Sharps Technology Inc. News
11/18/24 Sharps Regains Nasdaq Listing Compliance
10/14/24 Sharps Technology, Inc. Announces Stockholders’ Approval of Reverse Stock Split Ratio and Effective Date
10/09/24 Empery Asset Management's Strategic Reduction in Sharps Technology Inc
09/30/24 Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024
09/27/24 Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)
09/24/24 Sharps Technology, Inc. Closes $3.5 Million Bridge Financing
09/23/24 Sharps Technology, Inc. Announces $3.5 Million Bridge Financing
09/12/24 Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting
07/25/24 Sharps Technology Enters Into a Five-Year Sales Agreement with Strategic U.S. Medical Products Company Creating +$5O Million in New Revenue for EU Facility
07/09/24 Sharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting Deadline
07/03/24 Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery
07/03/24 Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024
06/17/24 Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in Colombia
06/14/24 Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18
06/13/24 Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility
06/07/24 Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
06/05/24 Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit
05/31/24 Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
05/30/24 Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
05/28/24 Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes
STSS Chatroom

User Image confucius_trader Posted - 54 minutes ago

$STSS strong finish. The PR will shoot this thing way up.

User Image ItTakesItAll Posted - 3 hours ago

Thursday in review: $BDRX 70%+ $CDT 60%+ $CRKN 30%+ $STSS 25%+ $BSLK 20%+ ANTX IBG 15%+ GXAI 10%+ Plenty opportunities for 5-10% every day! $400 - $ 400K challenge, still holding my 459 shares of SCPXD, down 26%. I'll be out for couple weeks returning after Thanksgiving. Grateful for life, family and my Savior Jesus Christ! Enjoy your evening.

User Image Scooter0619 Posted - 5 hours ago

$STSS Unless the company closes the Nephron deal, STSS will never be profitable. The Hungary plant is a losing proposition. They manufacture crappy syringes that they can’t sell. What happened to the 1 million syringes they sent to the distributer in Columbia back in June? Nada.

User Image ZdP2 Posted - 6 hours ago

$STSS Already up 20%, and PR hasn't even dropped yet. 👌

User Image ItTakesItAll Posted - 7 hours ago

$STSS 25%+ from 2.77-3.49

User Image MarketPro Posted - 7 hours ago

$STSS

User Image ZdP2 Posted - 12 hours ago

$STSS Our local basher made a new account. 🤣🤡

User Image Nikeke Posted - 13 hours ago

$STSS This stock is a trash stock. It's going to go back to $1 after less than $4.5. If you buy it, it's delisted.

User Image ItTakesItAll Posted - 1 day ago

Wednesday in review: $TNXP 140%+ from .1330-.3224 $CRKN 20%+ from .95-1.17 $STSS 15%+ from 2.77-3.30 $SOAR 10%+ Slow day for me many opportunities building up! $400 - $ 400K still holding my 459 shares of $SCPXD, down 26%. Good evening!

User Image pieintheskyguy Posted - 1 day ago

$STSS so what is the new strike price on the tradeable warrants? I've lost track.

User Image ItTakesItAll Posted - 1 day ago

$STSS 15%+ from 2.77-3.30 right direction, needs volume.

User Image confucius_trader Posted - 1 day ago

$STSS still have a very very very long ways to go to get to their IPO price. The reverse split made it almost impossible. Their ipo price was $3.20 before the split. My average price was $1.90 before the split. Now I need this to get to $30 just to break even. So we have a long long ways to go.

User Image jendivest Posted - 1 day ago

$STSS Really surprised we haven’t seen any news. Something has got to be dropping through PR soon …. ?

User Image ZdP2 Posted - 1 day ago

$STSS Looking good, still think this will hit 5$ again soon.

User Image ejcskwl Posted - 1 day ago

$STSS $30

User Image ItTakesItAll Posted - 2 days ago

$STSS Adding, very careful, aegis is here.

User Image ZdP2 Posted - 2 days ago

$STSS Algos turning bullish ? Up 12% on a trade of only 100 stocks. Offering at 3.6$, balance sheet looking good. Pump coming soon imo. The RVP bagholder below doesn't have a clue of when to buy or sell a stock, and likes to drink his own Kool-Aide 😅

User Image Scooter0619 Posted - 3 days ago

$STSS The company just announced an offering to sell 1,945,592 shares to the public on a best efforts basis. The offering is 100% dilution of the shares outstanding. It looks like they have to borrow from Peter to payback Paul( bridge loan of $4.3 million due on January 25th 2025). Longs keep drinking the Kool-Aide.

User Image ZdP2 Posted - 3 days ago

$STSS Compliant again. Nasdaq notified the Company on November 13, 2024 that the Company regained compliance on November 5, 2024 with Listing Rule 5550(a)(2), (the “Bid Price Rule”).

User Image ZdP2 Posted - 6 days ago

$STSS 👇 This frustrated goofball @Scooter0619 again. He somehow thinks trashing STSS will make up for his own bad investment choice in RVP (a competitor of STSS). He stopped posting bullish stuff on the RVP board (since it keeps going down), but somehow (and even though I think he never even bought STSS) he feels like he has to keep lurking around on this board. It's sad to see, I almost feel sorry for him. 😅

User Image Scooter0619 Posted - 1 week ago

$STSS 10q out: No sales Losing 2 million this quarter Being sued by the inventor of their syringe Barry Berler for non payment of $456,000 Being sued by their molding company Plastamold for non payment of invoices for $1.72 million Will have to raise additional cash this quarter. Who in hell will lend them $50 million to purchase the InjectEZ plant from Nephron?

User Image ZdP2 Posted - 1 week ago

$STSS 10-Q out. Nothing unexpected in it. Enough cash to bridge the next quarter or 2. OS at 1.8M. Aiming for 5$ in the short term.

User Image ZdP2 Posted - 1 week ago

$STSS Entered again at 2.95. Micro-float, this can run fast on good news.

User Image SupraFastAlerts Posted - 1 week ago

$STSS 👍

User Image ZdP2 Posted - 1 week ago

$STSS Nasdaq compliancy and likely a PR about a new sales deal next week. Still nothing about Nephron though, but the news might be good enough for a 20~40% pump from here.

User Image stockmet Posted - 1 week ago

$STSS curling back up 📈

User Image SupraFastAlerts Posted - 1 week ago

$STSS Same setup I mentioned earlier in the week for continuation toward 3.20-30s next

User Image ZdP2 Posted - 1 week ago

$STSS I'm inclined to buy some again. If this hits 2.5$ again I might bite.

User Image confucius_trader Posted - 1 week ago

$STSS every etf, mutual fund, and other company in my portfolio has been up since the election except this one. It’s a dog shit company.

User Image confucius_trader Posted - 1 week ago

$STSS the only reason for the reverse split was to avoid being delisted. They have nothing. No revenue. No products. No distribution contracts. No contracts executed. They have pawn for a CEO.

Analyst Ratings
Aegis Capital Buy May 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Jan 31 Buy 0.37 10,200 3,774 75,882 02/05/24
Ruemler Timothy James Director Director Jan 02 Buy 0.4 9,466 3,786 1,061,675 01/04/24
Crescenzo Andrew R. Chief Financial Offi.. Chief Financial Officer Dec 28 Buy 0.4216 3,500 1,476 15,500 12/29/23
Ruemler Timothy James Director Director Dec 22 Buy 0.4016 10,000 4,016 1,052,209 12/22/23
Ruemler Timothy James Director Director Nov 22 Buy 0.45 10,000 4,500 1,042,209 11/27/23
Ruemler Timothy James Director Director Nov 17 Buy 0.41 15,000 6,150 1,022,209 11/21/23
Ruemler Timothy James Director Director Nov 15 Buy 0.41 6,000 2,460 1,017,209 11/17/23
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Apr 14 Buy 1.28 4,000 5,120 65,682 04/18/23
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Mar 13 Buy 1.36 5,100 6,936 61,682 03/15/23
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Feb 17 Buy 1.36 3,500 4,760 56,582 02/22/23
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Sep 02 Buy 1.35 5,000 6,750 53,082 09/07/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Aug 30 Buy 1.35 8,073 10,899 48,082 09/01/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Aug 26 Buy 1.41 4,009 5,653 40,009 08/30/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Aug 22 Buy 1.29 4,000 5,160 36,000 08/24/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Aug 04 Buy 1.15 2,000 2,300 32,000 08/08/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer May 20 Buy 1.21 5,000 6,050 25,000 05/23/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Apr 27 Buy 1.48 4,000 5,920 14,000 05/02/22
Blackman Alan R. CIO and COO CIO and COO Apr 22 Buy 1.52 5,000 7,600 728,429 04/25/22
Ruemler Timothy James Director Director Apr 14 Buy 4.25 29,400 124,950 890,406 04/18/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Apr 14 Buy 2.06 7,000 14,420 7,000 04/18/22
Blackman Alan R. CIO and COO CIO and COO Apr 14 Buy 4.25 4,000 17,000 723,429 04/18/22